NUZ 5.26% 20.0¢ neurizon therapeutics limited

MONEPANTEL - A Pan-Cancer Wonder Drug, page-83

  1. 747 Posts.
    lightbulb Created with Sketch. 1558
    I think what @adreamer just posted is in line with my thinking here @Jakjazz - absolutely no objection a obtaining a valuation, but it is not the right tool for driving the SP higher. As I mentioned, a valuation of IP being considered for a licensing deal or sale etc. would be a different matter.

    I was responding to the proposition that a valuation would put a floor under the SP - it won't.

    As @adreamer has mentioned, a valuation of IP that's part of a transaction of some sort should be a given.

    Cheers

    Densy
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $106.8K 532.4K

Buyers (Bids)

No. Vol. Price($)
2 99579 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 102832 5
View Market Depth
Last trade - 15.42pm 11/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.